Researchers from the Institute of Bioengineering and Nanotechnology (IBN) and IBM Research today unveiled the first-ever antimicrobial hydrogel that can break apart biofilms and destroy multidrug-resistant superbugs upon contact. Tests have demonstrated the effectiveness of this novel synthetic material in eliminating various types of bacteria and fungi that are leading causes of microbial infections, and preventing them from developing antibiotic resistance. This discovery may be used in wound healing, medical device and contact lens coating, skin infection treatment and dental fillings.
The world's smallest tunnels have a width of a few nanometers only. Researchers from Karlsruhe Institute of Technology (KIT) and Rice University, USA, have dug such tunnels into graphite samples. This will allow structuring of the interior of materials through self-organization in the nanometer range and tailoring of nanoporous graphite for applications in medicine and battery technology. Results are now presented in the scientific journal Nature Communications (DOI: 10.1038/ncomms2399).
A UT Arlington bioengineering researcher has teamed with a UT Southwestern colleague to develop a nanoparticle drug delivery system that will help stimulate lung growth and function after partial lung removal or destructive lung disease.
It stiffens when heated and retains moisture a hundred times better than other gels. Chemists at Radboud University Nijmegen have created a gel made from helical polymers. The molecules twist together to form a ‘nano rope’, from which strong, stiff networks are produced. What is unusual is that a solution of the material is liquid when cold and turns into a gel when warmed – exactly the opposite of what happens to gelatine, for example. The leading scientific journal Nature published a paper showing how the ‘super gel’ works and its properties on 24 January. Together with the business community, the researchers are also developing various biomedical applications for this extraordinary gel.
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment.
How do you annihilate lymphoma without using any drugs?
Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer’s disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).
Biomedical researchers studying aging and cancer are intensely interested in telomeres, the protective caps on the ends of chromosomes. In a new study, scientists at UC Santa Cruz used a novel technique to reveal structu...
To live is to move. You strike to swat that irritable mosquito, which skilfully evades the hand of death. How did that happen? Who moved your hand, and what saved the mosquito? Enter the Molecular Motors, nanoscale protein-machines in the muscles of your hand and wings of the mosquito. You need these motors to swat mosquitoes, blink your eyes, walk, eat, drink... just name it. Millions of motors tug as a team within your muscles, and you swat the mosquito. This is teamwork at its exquisite best.
NanoSmart Pharmaceuticals, a private biotechnology company, has entered into a research collaboration agreement with University of California Los Angeles (UCLA) to continue the development of NanoSmart's novel drug d...
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.